CRP and neoplasm: Clinical information (such as age, sex, tumor stage and grade), blood examination (such as C-reactive protein, albumin ratio), tumor characteristics (such as metabolic tumor volume and total lesion glycolysis) and treatment methods (such as chemoradiotherapy, chemotherapy and surgery) have been regarded as prognostic factors and proved to be associated with the prognosis of patients with ESCA [30–33].